Gainers
- AcelRx Pharmaceuticals ACRX stock increased by 38.9% to $0.36 during Wednesday's after-market session. AcelRx Pharmaceuticals's trading volume hit 4.7 million shares by close, accounting for 336.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $52.9 million.
- Clearside Biomedical CLSD stock rose 14.17% to $1.61. The market value of their outstanding shares is at $96.8 million.
- Quotient QTNT stock increased by 8.43% to $0.27. Today's trading volume for this security ended up closing at 3.7 million shares, which is 242.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $36.6 million.
- Agile Therapeutics AGRX stock rose 8.42% to $0.74. Trading volume for this security closed at 3.2 million, accounting for 21.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.3 million.
- Qualigen Therapeutics QLGN shares increased by 7.89% to $0.54. The company's market cap stands at $20.9 million.
- Stealth BioTherapeutics MITO stock rose 7.88% to $0.24. The market value of their outstanding shares is at $17.5 million.
Losers
- CytomX Therapeutics CTMX shares decreased by 28.9% to $1.4 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 811.9K shares, which is 74.4 percent of its average volume over the last 100 days. The company's market cap stands at $91.5 million.
- Vor Biopharma VOR shares declined by 10.99% to $4.54. The market value of their outstanding shares is at $170.6 million.
- Titan Pharmaceuticals TTNP stock decreased by 8.91% to $0.82. Today's trading volume for this security ended up closing at 437.3K shares, which is 92.4 percent of its average volume over the last 100 days. The company's market cap stands at $11.9 million.
- SomaLogic SLGC stock fell 6.91% to $4.45. The company's market cap stands at $811.1 million.
- Adagio Therapeutics ADGI stock decreased by 6.09% to $3.55. The market value of their outstanding shares is at $389.5 million.
- Adverum Biotechnologies ADVM stock declined by 5.7% to $1.16. The company's market cap stands at $114.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in